Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
cap-232 (2 trials)
cαstx1 (1 trial)
cαstx2 (1 trial)
diazepinomicin (2 trials)
Bacterial Infections (Phase 2)
Carcinoma (Phase 2)
Carcinoma, Renal Cell (Phase 2)
Glioblastoma (Phase 2)
Glioma (Phase 1)
Infections (Phase 2)
Melanoma (Phase 2)
Trials (5 total)
Trial APIs (4 total)